Rhode Island 2025 Regular Session

Rhode Island House Bill H5116

Introduced
1/22/25  

Caption

Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.

Companion Bills

No companion bills found.

Similar Bills

RI H5079

Pharmaceutical Cost Transparency

RI H7116

Pharmaceutical Cost Transparency

RI H7140

Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.

CA AB2203

Insulin cost-sharing cap.

NJ S323

Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

NJ A3245

Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

NJ A1646

Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

NJ A1747

Establishes Prescription Drug Affordability Board; appropriates $1 million.